Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR.
Avvedimento M, Cepas-Guillén P, Ternacle J, Urena M, Alperi A, Cheema A, Veiga G, Nombela-Franco L, Vilalta V, Esposito G, Campelo-Parada F, Indolfi C, Del Trigo M, Muñoz-Garcia A, Maneiro-Melón NM, Asmarats L, Regueiro A, Del Val D, Serra V, Auffret V, Modine T, Bonnet G, Mesnier J, Suc G, Avanzas P, Rezaei E, Fradejas-Sastre V, Tirado-Conte G, Fernandez-Nofrerias E, Franzone A, Guitteny T, Sorrentino S, Oteo JF, Nuche J, Gutiérrez-Alonso L, Flores Umanzor E, Alfonso F, Monastyrski A, Nolf M, Côté M, Mehran R, Morice MC, Capodanno D, Garot P, Rodés-Cabau J.
Avvedimento M, et al. Among authors: indolfi c.
Circ Cardiovasc Interv. 2024 Oct 30. doi: 10.1161/CIRCINTERVENTIONS.124.014800. Online ahead of print.
Circ Cardiovasc Interv. 2024.
PMID: 39475194
Free article.